Rein Therapeutics Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2015 | $-11.7M | $-11.8M | $94.0K | $626.0K |
| FY2016 | $-15.0M | $-15.0M | — | $688.0K |
| FY2017 | $-20.5M | $-20.7M | $142.0K | $1.7M |
| FY2018 | $-27.9M | $-32.3M | $4.4M | $3.3M |
| FY2019 | $-26.5M | $-26.6M | $151.0K | $2.1M |
| FY2020 | $-20.5M | $-20.5M | $5.0K | $1.9M |
| FY2021 | $-23.8M | $-23.9M | $157.0K | $2.3M |
| FY2022 | $-24.9M | $-24.9M | — | $2.1M |
| FY2023 | $-19.8M | $-19.8M | — | $1.2M |
| FY2024 | $-22.3M | $-22.3M | — | $1.1M |
| FY2025 | $-19.4M | $-19.4M | — | $2.2M |